ARID1A: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 35: | Line 35: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 02:51, 17 March 2025
ARID1A is a gene that encodes a protein involved in chromatin remodeling, a critical process for the regulation of gene expression. The ARID1A protein is a component of the SWI/SNF complex, which is responsible for the rearrangement of chromatin structure. Mutations in the ARID1A gene have been associated with a variety of cancers, including ovarian cancer, endometrial cancer, and gastric cancer.
Function[edit]
The ARID1A gene encodes a protein that is part of the SWI/SNF complex. This complex is involved in chromatin remodeling, which is a process that alters the structure of chromatin to allow or prevent the transcription of genes. The ARID1A protein specifically is thought to regulate the binding of the SWI/SNF complex to chromatin.
Clinical significance[edit]
Mutations in the ARID1A gene have been implicated in a variety of cancers. These mutations often result in a loss of function of the ARID1A protein, which can lead to unregulated gene expression and the development of cancer.
Ovarian cancer[edit]
ARID1A mutations are particularly common in clear cell carcinoma of the ovary and endometrioid carcinoma of the ovary. These mutations are often associated with a poor prognosis.
Endometrial cancer[edit]
ARID1A mutations have also been identified in endometrial cancer. These mutations are often associated with a more aggressive form of the disease.
Gastric cancer[edit]
In gastric cancer, ARID1A mutations are often associated with a poor prognosis. These mutations are particularly common in gastric adenocarcinoma.
See also[edit]
